Journal Article
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy
Marianna Colagrande, Mauro Di Ianni, Gino Coletti, Ketty Peris and Maria Concetta Fargnoli, et al.
International Journal of Hematology, 2009, Volume 89, Number 1, Pages 76-79
Book Chapter
Treatment of Myeloproliferative Neoplasms
Starla Sweany and Elias Jabbour
Contemporary Hematology, 2010, Neoplastic Hematopathology, Part 2, Pages 213-220
Journal Article
Acquired Hb H disease associated with elevated Hb F level in patient affected by primary myelofibrosis
Ciro Roberto Rinaldi, Paola Rinaldi, Fabrizio Pane, Andrea Camera and Carmine Rinaldi
Annals of Hematology, 2010, Volume 89, Number 8, Pages 827-828
Journal Article
Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy
Ali T. Taher, Khaled M. Musallam, Suzane Koussa and Adlette Inati
Annals of Hematology, 2009, Volume 88, Number 12, Pages 1263-1264
Journal Article
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients
Alejandra Martínez-Trillos, Anna Gaya, Margherita Maffioli, Eduardo Arellano-Rodrigo and Xavier Calvo, et al.
Annals of Hematology, 2010, Volume 89, Number 12, Pages 1233-1237
Reference Work Entry
Myeloproliferative Disorders and the Chronic Leukemias: Symptom Burden and Impact in Quality of Life
R. A. Mesa, D. P. Steensma and T. Shanafelt
2010, Handbook of Disease Burdens and Quality of Life Measures, Part 3, 3.4, Pages 2887-2904
Journal Article
New Drugs for the Treatment of Myelofibrosis
Ruben A. Mesa
Current Hematologic Malignancy Reports, 2010, Volume 5, Number 1, Pages 15-21
Journal Article
Future Therapies for the Myeloproliferative Neoplasms
Robyn Scherber and Ruben A. Mesa
Current Hematologic Malignancy Reports, 2011, Volume 6, Number 1, Pages 22-27
Journal Article
Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status
J. M. Raya, L. Arenillas, A. Domingo, B. Bellosillo and G. Gutiérrez, et al.
International Journal of Hematology, 2008, Volume 88, Number 4, Pages 387-395
Journal Article
Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis
Yutaka Hattori, Yoshitaka Miyakawa, Kenji Yokoyama, Taketo Yamada and Wenlin Du, et al.
International Journal of Hematology, 2011, Volume 93, Number 1, Pages 129-131